Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2023

Open Access 01-12-2023 | Epilepsy | Study Protocol

The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt

Authors: Ji Shuming, Li Hua, Tang Yusha, Chen Lei

Published in: BMC Neurology | Issue 1/2023

Login to get access

Abstract

Background

A significant proportion of patients with epilepsy have an unknown etiology and lack effective targeted therapeutic drugs. Patent Foramen Ovale (PFO) induces hypoxia and microembolism, leading to cerebral neurological dysfunction and increased epilepsy risk. This study aims to assess the efficacy and safety of PFO closure for relieving epileptic seizures in patients with refractory epilepsy associated with PFO.

Methods/design

Recruitment takes place at the West China Hospital of Sichuan University, China, for an open-label, randomized controlled clinical trial. The trial will include 110 patients with refractory epilepsy and PFO. Disease diagnoses will conform to the diagnostic criteria of the International League Against Epilepsy (ILAE) for refractory epilepsy and the American Society of Echocardiography (ASE) for PFO. Refractory epilepsy and high-grade right-to-left shunt (RLS) of the PFO will be further diagnosed using 24-hour video electroencephalogram and transthoracic echocardiography with contrast injection, respectively. Eligible participants require a secondary or higher volume of RLS.

Trial registration

Chinese Clinical Trial Registry (ChiCTR2200065681). Registered on November 11, 2022.
Appendix
Available only for authorised users
Literature
1.
Teshome MK, et al. Patent Foramen Ovale: a Comprehensive Review. Curr Probl Cardiol. 2020;45(2):100392.CrossRefPubMed
2.
3.
Le Moigne E, et al. Patent Foramen Ovale and ischemic stroke in patients with Pulmonary Embolism: a prospective cohort study. Ann Intern Med. 2019;170(11):756–63.CrossRefPubMed
4.
Cao W et al. The patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI evidence. Brain Sci, 2022. 12(7).
5.
6.
Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache. 2006;46(3):429–34.CrossRefPubMed
7.
8.
Lopez MF, et al. Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux. Clin Proteom. 2015;12(1):2.CrossRef
9.
Bridges ND, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86(6):1902–8.CrossRefPubMed
10.
Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interv Cardiol. 2003;16(6):543–51.CrossRefPubMed
11.
Akagi T. Transcatheter closure of patent foramen ovale: current evidence and future perspectives. J Cardiol. 2021;77(1):3–9.CrossRefPubMed
12.
Wintzer-Wehekind J, et al. Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism. J Am Coll Cardiol. 2019;73(3):278–87.CrossRefPubMed
13.
Saver JL, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022–32.CrossRefPubMed
14.
Mojadidi MK, et al. Pooled analysis of pfo occluder device trials in patients with pfo and migraine. J Am Coll Cardiol. 2021;77(6):667–76.CrossRefPubMed
15.
16.
Kavinsky CJ, et al. SCAI guidelines for the management of patent foramen ovale. J Soc Cardiovasc Angiography Interventions. 2022;1(4):100039.CrossRef
17.
18.
Collaborators GE. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(4):357–75.CrossRef
19.
Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. Handb Clin Neurol. 2012;107:113–33.CrossRefPubMed
20.
Ryvlin P, Cucherat M, Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol. 2011;10(11):961–8.CrossRefPubMed
21.
Collaborators GN. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80.CrossRef
22.
Nye BL, Thadani VM. Migraine and epilepsy: review of the literature. Headache. 2015;55(3):359–80.CrossRefPubMed
23.
Zarcone D, Corbetta S. Shared mechanisms of epilepsy, migraine and affective disorders. Neurol Sci. 2017;38(Suppl 1):73–6.CrossRefPubMed
24.
Cho KK, et al. Persistent pathology of the patent foramen ovale: a review of the literature. Med J Aust. 2021;215(2):89–93.CrossRefPubMed
25.
Fiest KM, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296–303.CrossRefPubMedPubMedCentral
26.
Kessler KM. The CONSORT statement: explanation and elaboration. Consolidated Standards of reporting trials. Ann Intern Med. 2002;136(12):926–7. author reply 926-7.CrossRefPubMed
27.
Chow JTY, et al. Sample size calculations for randomized clinical trials published in anesthesiology journals: a comparison of 2010 versus 2016. Can J Anaesth. 2018;65(6):611–8.CrossRefPubMed
Metadata
Title
The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt
Authors
Ji Shuming
Li Hua
Tang Yusha
Chen Lei
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2023
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-023-03317-0

Other articles of this Issue 1/2023

BMC Neurology 1/2023 Go to the issue

Research

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study

Study Protocol

Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates

Research

Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan

Case Report

Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

Case Report

Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report

Research article

EEG spectral power during REM sleep in patients with frontal brain tumor